ICD-10-CM Tabular Index · Chapter 2 · FY 2027 D34

Benign neoplasm of thyroid gland (D34) ICD-10-CM

The D34 code range covers benign neoplasm of thyroid gland with 1 ICD-10-CM diagnosis codes. 1 of them are billable and valid for claim submission in fiscal year 2027, and the category headers group them but cannot themselves be billed.

✓ Built from the official CMS FY 2027 datasetEffective Oct 1, 2026 – Sep 30, 2027
1
Diagnosis Codes
1
Billable Codes
D34
Code Range
D10–D36
Parent Section

Use Additional Code

The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.

ICD-10-CM

Codes in the D34 Range 1 codes · 1 billable

1 of 1 shown
  • D34 Benign neoplasm of thyroid gland

Clinical Terms in This Code Range

Definitions from the National Library of Medicine for conditions coded in the D34 range.

Benign Thyroid Gland Neoplasm

A neoplasm that arises from the thyroid gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.

About the D34 Code Range

Benign thyroid neoplasms are growths that arise in the thyroid gland without malignant features, invasion, or the potential to spread.

Within benign neoplasms other than benign neuroendocrine tumors, D34 identifies the thyroid gland as the site.

Questions About This Page

How many billable codes are in the D34 range?

Of the 1 codes in this range, 1 are billable and valid for claim submission from October 1, 2026 through September 30, 2027. Category header codes group them but cannot be reported on claims.

What does the D34 range classify?

The range classifies benign neoplasm of thyroid gland. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.

Related References

Source: CMS FY 2027 ICD-10-CM Tabular List and order file, effective October 1, 2026 through September 30, 2027.